mRNA-Based Vaccine for COVID-19: They Are New but Not Unknown!
Open Access
Abstract
MRNA vaccines take advantage of the mechanism that our cells use to produce proteins. Our cells produce proteins based on the knowledge contained in our DNA; each gene encodes a unique protein. The genetic information is essential, but cells cannot use it until mRNA molecules convert it into instructions for producing specific proteins. mRNA vaccinations provide ready-to-use mRNA instructions for constructing a specific protein. BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) both are newly approved mRNA-based COVID-19 vaccines that have shown excellent protection and efficacy. In total, there are five more mRNA-based vaccine candidates for COVID-19 under different phases of clinical development. This review is specifically focused on mRNA-based vaccines for COVID-19 covering its development, mechanism, and clinical aspects.Keywords
This publication has 110 references indexed in Scilit:
- Regulation of Poly(A) Tail and Translation during the Somatic Cell CycleMolecular Cell, 2016
- mRNA Vaccine Delivery Using Lipid NanoparticlesTherapeutic Delivery, 2016
- Prime-boost vaccine strategy against viral infections: Mechanisms and benefitsVaccine, 2016
- The messenger's great message for vaccinationExpert Review of Vaccines, 2015
- A Cationic Nanoemulsion for the Delivery of Next-generation RNA VaccinesMolecular Therapy, 2014
- mRNA-based therapeutics — developing a new class of drugsNature Reviews Drug Discovery, 2014
- Inhibition of translation by IFIT family members is determined by their ability to interact selectively with the 5′-terminal regions of cap0-, cap1- and 5′ppp- mRNAsNucleic Acids Research, 2013
- Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with Plasmid Interleukin 12 and Impact of Intramuscular Electroporation for DeliveryThe Journal of Infectious Diseases, 2013
- DNA Vaccines: Developing New Strategies against CancerJournal of Biomedicine and Biotechnology, 2010
- In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodiesEuropean Journal of Immunology, 2000